NHAS
AVLN

Novo Holdings A/S’s Avalyn Pharma AVLN Stock Holding History

Novo Holdings A/S’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Buy
+3,883,289
New +$112M 7.42% 7

Other funds holding AVLN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Novo Holdings A/S's AVLN Position: Q2 2026 in Review

Novo Holdings A/S opened a new position in Avalyn Pharma (AVLN) in Q2 2026: 3,883,289 shares worth $128M. The stake represents 7.42% of the portfolio and ranks #7 among its holdings.

81 funds tracked by Wall St. Rank hold AVLN as of Q2 2026.

  • Novo Holdings A/S held 3,883,289 shares of Avalyn Pharma worth $128M as of Q2 2026.
  • Avalyn Pharma was a new Novo Holdings A/S position in Q2 2026.
  • Avalyn Pharma made up 7.42% of Novo Holdings A/S's portfolio in Q2 2026, its #7 holding.
  • 81 funds tracked by Wall St. Rank held Avalyn Pharma as of Q2 2026.

Based on Novo Holdings A/S's 13F filing for Q2 2026, filed 14 Aug 2026.